| 1 | Activated prothrombin complex concentrate | [1] Anti-inhibitor coagulant complex Anti-inhibitor coagulant complex | [1] Human blood-coagulation factor eight inhibitor bypassing activity complex, dried
Human blood-coagulation factor eight inhibitor bypassing activity complex, dried
💬
| - | - | [1] 288 288 💬
|
| 2 | Advate | [1] Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | [1] Octocog alfa
Octocog alfa
💬
| [1] F8 F8 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 288 288 💬
|
| 3 | Advate 1000 IU | [1] Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | [1] Octocog alfa
Octocog alfa
💬
| [1] F8 F8 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 288 288 💬
|
| 4 | Advate 1000 IU powder and solvent FOR solution FOR injection | [1] Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | [1] Octocog alfa
Octocog alfa
💬
| [1] F8 F8 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 288 288 💬
|
| 5 | Advate 1000IU powder and solvent FOR solution FOR injection | [1] Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | [1] Octocog alfa
Octocog alfa
💬
| [1] F8 F8 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 288 288 💬
|
| 6 | Advate 500 IU powder and solvent FOR solution FOR injection | [1] Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | [1] Octocog alfa
Octocog alfa
💬
| [1] F8 F8 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 288 288 💬
|
| 7 | Alphanate | [3] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
| 8 | Alphanate SD/HT | - | - | - | - | [1] 288 288 💬
|
| 9 | Alphanate*INF 1F 1000UI+F 10ML | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬
|
| 10 | Alphanate*INF 1F 1500UI+F 10ML | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬
|
| 11 | Alphanate*INF 1F 250UI+F 5ML | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬
|
| 12 | Alphanate*INF 1F 500UI+F 5ML | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬
|
| 13 | Apcc, apcc + TXA | - | - | - | - | [1] 288 288 💬
|
| 14 | ARC 1779 | - | - | - | - | [2] 64 64, 288 💬
|
| 15 | ARC1779 | - | - | - | - | [2] 64 64, 288 💬
|
| 16 | ARC1779 injection | - | - | - | - | [2] 64 64, 288 💬
|
| 17 | BAX 111 | - | - | - | - | [1] 288 288 💬
|
| 18 | BAX111 | - | - | - | - | [1] 288 288 💬
|
| 19 | Biostate | - | - | - | - | [1] 288 288 💬
|
| 20 | Blood coagulation factor viii and VWF, human | - | - | - | - | [1] 288 288 💬
|
| 21 | Blood sample | - | - | - | - | [28] 2 2, 3, 8, 13, 34, 46, 49, 51, 53, 61, 65, 66, 67, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 280, 288, 294, 299 💬
|
| 22 | Bortezomib | [2] Bortezomib Bortezomib, Bortezomib D-mannitol | [1] Bortezomib
Bortezomib
💬
| [1] PSMB5 PSMB5 💬
| [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [16] 11 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 172, 222, 228, 256, 288, 331 💬
|
| 23 | BT200 | [1] BT200 BT200 | - | - | - | [1] 288 288 💬
|
| 24 | Catridecacog | [1] Catridecacog Catridecacog | [1] Catridecacog
Catridecacog
💬
| - | - | [2] 97 97, 288 💬
|
| 25 | Cluvot | - | - | - | - | [1] 288 288 💬
|
| 26 | Coagadex | - | - | - | - | [2] 28 28, 288 💬
|
| 27 | CoagulacióN factor viii | - | - | - | - | [1] 288 288 💬
|
| 28 | Coagulation factor viii | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬
|
| 29 | Coagulation factor xiii | [1] Factor XIII (human) Factor XIII (human) | - | - | - | [1] 288 288 💬
|
| 30 | Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [44] 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 224, 265, 274, 283, 284, 285, 288, 326, 331 💬
|
| 31 | Daratumumab and corticosteroid treatment | [1] Daratumumab Daratumumab | [1] Daratumumab
Daratumumab
💬
| [1] CD38 CD38 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [1] 288 288 💬
|
| 32 | Ddavp | [1] Desmopressin Desmopressin | [2] Desmopressin
Desmopressin
,
Desmopressin acetate
💬
| [2] AVPR2 AVPR2, F8 💬
| [5] Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [3] 75 75, 225, 288 💬
|
| 33 | Desmopressin | [1] Desmopressin Desmopressin | [2] Desmopressin
Desmopressin
,
Desmopressin acetate
💬
| [2] AVPR2 AVPR2, F8 💬
| [5] Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [3] 64 64, 75, 288 💬
|
| 34 | Desmopressin acetate | [1] Desmopressin Desmopressin | [2] Desmopressin
Desmopressin
,
Desmopressin acetate
💬
| [2] AVPR2 AVPR2, F8 💬
| [5] Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [2] 64 64, 288 💬
|
| 35 | Desmopressine | [1] Desmopressin Desmopressin | [2] Desmopressin
Desmopressin
,
Desmopressin acetate
💬
| [2] AVPR2 AVPR2, F8 💬
| [5] Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 288 288 💬
|
| 36 | Efanesoctocog alfa | [1] Efanesoctocog alfa Efanesoctocog alfa | [1] Efanesoctocog alfa
Efanesoctocog alfa
💬
| [1] F8 F8 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 288 288 💬
|
| 37 | Emicizumab | [1] Emicizumab Emicizumab | [1] Emicizumab
Emicizumab
💬
| [2] F10 F10, F9 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 288 288 💬
|
| 38 | Emicizumab injection | [1] Emicizumab Emicizumab | [1] Emicizumab
Emicizumab
💬
| [2] F10 F10, F9 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 288 288 💬
|
| 39 | Eqwilate | - | - | - | - | [1] 288 288 💬
|
| 40 | F13CD | - | - | - | - | [1] 288 288 💬
|
| 41 | F8VR | - | - | - | - | [1] 288 288 💬
|
| 42 | Factane 200 IU/ML | - | - | - | - | [1] 288 288 💬
|
| 43 | Factor viii concentrate | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬
|
| 44 | Factor VON willebrand | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
| 45 | Factor X | [1] Coagulation factor X human Coagulation factor X human | - | - | - | [1] 288 288 💬
|
| 46 | Factor xiii | [1] Factor XIII (human) Factor XIII (human) | - | - | - | [3] 51 51, 97, 288 💬
|
| 47 | Factor xiii concentrate (human), pasteurized | [1] Factor XIII (human) Factor XIII (human) | - | - | - | [1] 288 288 💬
|
| 48 | Fanhdi | - | - | - | - | [1] 288 288 💬
|
| 49 | Fanhdi 100 UI | - | - | - | - | [1] 288 288 💬
|
| 50 | Fanhdi 100 UI fviii-120 UI FVW | - | - | - | - | [1] 288 288 💬
|
| 51 | Fanhdi 25 UI | - | - | - | - | [1] 288 288 💬
|
| 52 | Fanhdi 25 UI fviii-30 UI FVW | - | - | - | - | [1] 288 288 💬
|
| 53 | Fanhdi 250UI*1F 250UI+F 10ML | - | - | - | - | [1] 288 288 💬
|
| 54 | Fanhdi 50 UI | - | - | - | - | [1] 288 288 💬
|
| 55 | Fanhdi 50 UI fviii-60 UI FVW | - | - | - | - | [1] 288 288 💬
|
| 56 | Fanhdi*INF FL 250UI+SIR solv+S | - | - | - | - | [1] 288 288 💬
|
| 57 | Fanhdi*INF FL 500UI+SIR solv+S | - | - | - | - | [1] 288 288 💬
|
| 58 | Fanhdi*INF FL1000UI+SIR solv+S | - | - | - | - | [1] 288 288 💬
|
| 59 | Fanhdi*INF FL250UI+SIR solv+S | - | - | - | - | [1] 288 288 💬
|
| 60 | Fibrinogen plasma concentration, coagulation factor xiii activity | [1] Fibrinogen human Fibrinogen human | [1] Fibrinogen I 125
Fibrinogen I 125
💬
| - | - | [1] 288 288 💬
|
| 61 | Fibrogammin | - | - | - | - | [1] 288 288 💬
|
| 62 | Fibrogammin P | - | - | - | - | [1] 288 288 💬
|
| 63 | Fibrogammin® P | - | - | - | - | [1] 288 288 💬
|
| 64 | Fibrogammin®P | - | - | - | - | [1] 288 288 💬
|
| 65 | Haemate P | - | - | - | - | [1] 288 288 💬
|
| 66 | Haemate-P, wilate | - | - | - | - | [1] 288 288 💬
|
| 67 | Haemate® P 250 | - | - | - | - | [1] 288 288 💬
|
| 68 | Hemofix | - | - | - | - | [1] 288 288 💬
|
| 69 | Human coagulation factor viii | [2] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa | - | - | - | [1] 288 288 💬
|
| 70 | Human coagulation factor viii / VON willebrand factor | [2] Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
| 71 | Human coagulation factor viii, VON willebrand factor | [2] Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
| 72 | Human coagulation factor viii, VON willebrand factor complex | [2] Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
| 73 | Human coagulation factor viii, VON willebrand human coagulation factor | [1] Antihemophilic factor human Antihemophilic factor human | - | - | - | [1] 288 288 💬
|
| 74 | Human coagulation factor X | [1] Coagulation factor X human Coagulation factor X human | - | - | - | [1] 288 288 💬
|
| 75 | Human factor X | [1] Coagulation factor X human Coagulation factor X human | - | - | - | [1] 288 288 💬
|
| 76 | Human VON willebrand factor | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
| 77 | Human VWF/fviii concentrate | - | - | - | - | [1] 288 288 💬
|
| 78 | Humate-P | [3] Beroctocog alfa Beroctocog alfa, Humate-P, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
| 79 | Hydrogen | [1] Hydrogen Hydrogen | - | - | - | [6] 5 5, 6, 17, 97, 226, 288 💬
|
| 80 | Lyophilized concentrate OF human coagulation VON willebrand factor and factor viii | - | - | - | - | [1] 288 288 💬
|
| 81 | Marketed plasma-derived VWF/fviii concentrate | - | - | - | - | [1] 288 288 💬
|
| 82 | Minirin | [1] Desmopressin Desmopressin | [2] Desmopressin
Desmopressin
,
Desmopressin acetate
💬
| [2] AVPR2 AVPR2, F8 💬
| [5] Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [2] 64 64, 288 💬
|
| 83 | Minrin | - | - | - | - | [1] 288 288 💬
|
| 84 | Natriumchlorid | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [1] 288 288 💬
|
| 85 | NN 1841 | - | - | - | - | [1] 288 288 💬
|
| 86 | NN1841 | - | - | - | - | [1] 288 288 💬
|
| 87 | OBI-1 | - | - | - | - | [1] 288 288 💬
|
| 88 | Obizur | - | - | - | - | [1] 288 288 💬
|
| 89 | Obyoctocog alfa | - | - | - | - | [1] 288 288 💬
|
| 90 | Octanate 100 UI/ML, poudre ET solvant pour solution injectable | - | - | - | - | [1] 288 288 💬
|
| 91 | Octanate 50 UI/ML, poudre ET solvant pour solution injectable | - | - | - | - | [1] 288 288 💬
|
| 92 | Octocog alfa | [1] Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | [1] Octocog alfa
Octocog alfa
💬
| [1] F8 F8 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 288 288 💬
|
| 93 | Octostim | - | - | - | - | [2] 64 64, 288 💬
|
| 94 | Oprelvekin, interleukin 11, IL-11 | [1] Oprelvekin Oprelvekin | [1] Oprelvekin
Oprelvekin
💬
| [1] IL11RA IL11RA 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | [1] 288 288 💬
|
| 95 | Optivate | - | - | - | - | [1] 288 288 💬
|
| 96 | Phosphate | [1] Phosphate ion Phosphate ion | - | - | - | [13] 3 3, 11, 13, 46, 65, 70, 75, 90, 235, 238, 256, 286, 288 💬
|
| 97 | Physiologische kochsalzlösung fresenius - infusionslösung | - | - | - | - | [1] 288 288 💬
|
| 98 | Phytomenadione | [1] Phylloquinone Phylloquinone | [1] Phytonadione
Phytonadione
💬
| - | - | [1] 288 288 💬
|
| 99 | Plasma-derived fviii/VWF concentrate | - | - | - | - | [1] 288 288 💬
|
| 100 | Prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [54] 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
|
| 101 | Prothrombin complex concentrate | [2] Factor IX Complex (Human) Factor IX Complex (Human), Prothrombin | [1] Factor IX complex
Factor IX complex
💬
| - | - | [1] 288 288 💬
|
| 102 | Rahf | [1] Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | [1] Octocog alfa
Octocog alfa
💬
| [1] F8 F8 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 288 288 💬
|
| 103 | Recombinant activated factor VII | - | - | - | - | [1] 288 288 💬
|
| 104 | Recombinant coagulation fviii FC – VON willebrand factor – xten fusion protein | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
| 105 | Recombinant coagulation fviii FC –VON willebrand factor – xten fusion protein | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
| 106 | Recombinant factor xiii | - | - | - | - | [1] 288 288 💬
|
| 107 | Recombinant human coagulation factor viii FC - VON willebrand facto | [1] Antihemophilic factor human Antihemophilic factor human | - | - | - | [1] 288 288 💬
|
| 108 | Recombinant human coagulation factor viii FC - VON willebrand factor - xten fusion protein | - | - | - | - | [1] 288 288 💬
|
| 109 | Recombinant human coagulation factor viii FC - VON willebrand factor -xten fusion protein | [2] Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
| 110 | Recombinant human VON willebrand factor | - | - | - | - | [1] 288 288 💬
|
| 111 | Recombinant interleukin-11 | [1] Oprelvekin Oprelvekin | [1] Oprelvekin
Oprelvekin
💬
| [1] IL11RA IL11RA 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | [1] 288 288 💬
|
| 112 | Recombinant VON willebrand factor | - | - | - | - | [1] 288 288 💬
|
| 113 | Recombinant VON willebrand factor 1300IU | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
| 114 | Recombinant VON willebrand factor 650IU | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
| 115 | Recomibnant human VON willebrand factor | - | - | - | - | [1] 288 288 💬
|
| 116 | Rfviia, rfviia + TXA | [1] Coagulation factor VIIa Recombinant Human Coagulation factor VIIa Recombinant Human | [1] Eptacog alfa
Eptacog alfa
💬
| [1] F7 F7 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 288 288 💬
|
| 117 | Rfviii | - | - | - | - | [1] 288 288 💬
|
| 118 | Rituxan | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [7] 35 35, 46, 60, 61, 63, 256, 288 💬
|
| 119 | Rituximab | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [52] 11 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
| 120 | RO5534262 emicizumab | [1] Emicizumab Emicizumab | [1] Emicizumab
Emicizumab
💬
| [2] F10 F10, F9 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 288 288 💬
|
| 121 | Rondoraptivon pegol | [1] BT200 BT200 | - | - | - | [1] 288 288 💬
|
| 122 | Rurioctocog alfa pegol | [1] Rurioctocog alfa pegol Rurioctocog alfa pegol | [1] Rurioctocog alfa pegol
Rurioctocog alfa pegol
💬
| [1] F8 F8 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 288 288 💬
|
| 123 | Rvwf | - | - | - | - | [1] 288 288 💬
|
| 124 | Saline solution | - | - | - | - | [5] 2 2, 34, 46, 67, 288 💬
|
| 125 | Simvastatin | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [19] 6 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 158, 160, 195, 265, 288, 298, 299, 310 💬
|
| 126 | Simvastatine | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [3] 6 6, 13, 288 💬
|
| 127 | Sodium chloride | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [20] 2 2, 11, 13, 14, 34, 41, 46, 51, 53, 60, 67, 70, 96, 97, 193, 214, 215, 227, 288, 299 💬
|
| 128 | Standard OF care FOR haemophilia A | - | - | - | - | [1] 288 288 💬
|
| 129 | Standard OF care fviii replacement therapy | - | - | - | - | [1] 288 288 💬
|
| 130 | Steroid | - | - | - | - | [4] 70 70, 95, 107, 288 💬
|
| 131 | Sublingual videomicroscopy | - | - | - | - | [1] 288 288 💬
|
| 132 | Susoctocog alfa | [1] Susoctocog alfa Susoctocog alfa | [1] Susoctocog alfa
Susoctocog alfa
💬
| [1] F8 F8 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 288 288 💬
|
| 133 | TAK-577 | - | - | - | - | [1] 288 288 💬
|
| 134 | TAK-672 | - | - | - | - | [1] 288 288 💬
|
| 135 | Tranexamic acid | [1] Tranexamic acid Tranexamic acid | [1] Tranexamic acid
Tranexamic acid
💬
| [1] PLG PLG 💬
| [4] Complement and coagulation cascades Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬 | [8] 46 46, 65, 70, 215, 227, 274, 288, 299 💬
|
| 136 | USE OF A postpartum diary and additional blood draws | - | - | - | - | [1] 288 288 💬
|
| 137 | Veyondi 650IU powder and solvent FOR solution FOR injection | - | - | - | - | [1] 288 288 💬
|
| 138 | Veyvondi | - | - | - | - | [1] 288 288 💬
|
| 139 | Veyvondi 1300 IU powder and solvent FOR solution FOR injection | [1] Vonicog alfa Vonicog alfa | [1] Vonicog alfa
Vonicog alfa
💬
| - | - | [1] 288 288 💬
|
| 140 | Veyvondi 1300I IU powder and solvent FOR solution FOR injection | [1] Vonicog alfa Vonicog alfa | [1] Vonicog alfa
Vonicog alfa
💬
| - | - | [1] 288 288 💬
|
| 141 | Veyvondi 1300IU | [1] Vonicog alfa Vonicog alfa | [1] Vonicog alfa
Vonicog alfa
💬
| - | - | [1] 288 288 💬
|
| 142 | Veyvondi 1300IU powder and solvent FOR solution FOR injection | [1] Vonicog alfa Vonicog alfa | [1] Vonicog alfa
Vonicog alfa
💬
| - | - | [1] 288 288 💬
|
| 143 | Veyvondi 650IU | [1] Vonicog alfa Vonicog alfa | [1] Vonicog alfa
Vonicog alfa
💬
| - | - | [1] 288 288 💬
|
| 144 | Veyvondi 650IU powder and solvent FOR solution FOR injection | [1] Vonicog alfa Vonicog alfa | [1] Vonicog alfa
Vonicog alfa
💬
| - | - | [1] 288 288 💬
|
| 145 | VGA039 | [1] VGA039 VGA039 | - | - | - | [1] 288 288 💬
|
| 146 | VON willebrand factor | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [2] 63 63, 288 💬
|
| 147 | VON willebrand factor and coagulation factor viii IN combination | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
| 148 | VON willebrand factor antigen | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
| 149 | VON willebrand factor concentrates and factor viii concentrates | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
| 150 | VON willebrand factor ristocetin cofactor | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
| 151 | VON willebrand faktor | - | - | - | - | [1] 288 288 💬
|
| 152 | Voncento | [2] Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
| 153 | Vonicog alfa | [1] Vonicog alfa Vonicog alfa | [1] Vonicog alfa
Vonicog alfa
💬
| - | - | [1] 288 288 💬
|
| 154 | VWD factor viii concentrate | - | - | - | - | [1] 288 288 💬
|
| 155 | VWF gene analysis | - | - | - | - | [1] 288 288 💬
|
| 156 | VWF replacement therapy with wilate | - | - | - | - | [1] 288 288 💬
|
| 157 | VWF SD-35-DH | - | - | - | - | [1] 288 288 💬
|
| 158 | VWF-containing products | - | - | - | - | [1] 288 288 💬
|
| 159 | VWF/fviii products | - | - | - | - | [1] 288 288 💬
|
| 160 | Wilate | [2] Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
| 161 | Wilate 1000 | [2] Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
| 162 | Wilate 450 | [2] Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
| 163 | Wilate 500 | [2] Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
| 164 | Wilate 900 | [2] Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
| 165 | Wilate® 450 | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
| 166 | Wilfactin | - | - | - | - | [1] 288 288 💬
|
| 167 | Willfact | - | - | - | - | [1] 288 288 💬
|
| 168 | Wiloctin | - | - | - | - | [1] 288 288 💬
|